Medicine FDA Approves Takeda’s HyQvia for Maintenance of Chronic Inflammatory Demyelinating Polyneuropathy January 18, 2024 admin HyQvia is the only subcutaneous immune globulin infusion that can be administered once per month. Share Facebook Twitter Pinterest Linkedin
